BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 16133083)

  • 1. Recombinant coagulation factor VIIa--a novel haemostatic agent in scoliosis surgery?
    Kolban M; Balachowska-Kosciolek I; Chmielnicki M
    Eur Spine J; 2006 Jun; 15(6):944-52. PubMed ID: 16133083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gelatine matrix with human thrombin decreases blood loss in adolescents undergoing posterior spinal fusion for idiopathic scoliosis: a multicentre, randomised clinical trial.
    Helenius I; Keskinen H; Syvänen J; Lukkarinen H; Mattila M; Välipakka J; Pajulo O
    Bone Joint J; 2016 Mar; 98-B(3):395-401. PubMed ID: 26920966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant activated factor VII in spinal surgery: a multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial.
    Sachs B; Delacy D; Green J; Graham RS; Ramsay J; Kreisler N; Kruse P; Khutoryansky N; Hu SS
    Spine (Phila Pa 1976); 2007 Oct; 32(21):2285-93. PubMed ID: 17906567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.
    Bhaskar B; Zeigenfuss M; Choudhary J; Fraser JF
    Transfusion; 2013 Apr; 53(4):798-804. PubMed ID: 22845023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
    Razon Y; Erez E; Vidne B; Birk E; Katz J; Tamari H; Dagan O
    Paediatr Anaesth; 2005 Mar; 15(3):235-40. PubMed ID: 15725322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the Coagulation Profile of Adolescent Idiopathic Scoliosis Patients Undergoing Posterior Spinal Fusion With and Without Tranexamic Acid.
    Bosch P; Kenkre TS; Soliman D; Londino JA; Novak NE
    Spine Deform; 2019 Nov; 7(6):910-916. PubMed ID: 31732001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial.
    Pruthi RK; Mathew P; Valentino LA; Sumner MJ; Seremetis S; Hoots WK;
    Thromb Haemost; 2007 Oct; 98(4):726-32. PubMed ID: 17938794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safe use of recombinant activated factor VIIa for recalcitrant postoperative haemorrhage in cardiac surgery.
    Tatoulis J; Theodore S; Meswani M; Wynne R; Hon-Yap C; Powar N
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):459-62. PubMed ID: 19542087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.
    Caviglia H; Candela M; Galatro G; Neme D; Moretti N; Bianco RP
    Haemophilia; 2011 Nov; 17(6):910-9. PubMed ID: 21342367
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
    Chapman AJ; Blount AL; Davis AT; Hooker RL
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1314-8; discussion 1318-9. PubMed ID: 21601468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgery in patients with haemophilia and high responding inhibitors: Izmir experience.
    Balkan C; Karapinar D; Aydogdu S; Ozcan C; Ay Y; Akin M; Kavakli K
    Haemophilia; 2010 Nov; 16(6):902-9. PubMed ID: 20518817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factor VIII inhibitor bypass activity and recombinant activated factor VII in cardiac surgery.
    Rao VK; Lobato RL; Bartlett B; Klanjac M; Mora-Mangano CT; Soran PD; Oakes DA; Hill CC; van der Starre PJ
    J Cardiothorac Vasc Anesth; 2014 Oct; 28(5):1221-6. PubMed ID: 25281040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of factor VII-deficient patients undergoing joint surgeries--preliminary results of locally developed treatment regimen.
    Windyga J; Zbikowski P; Ambroziak P; Baran B; Kotela I; Stefanska-Windyga E
    Haemophilia; 2013 Jan; 19(1):89-93. PubMed ID: 22845882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high-titre inhibitor: a case report and literature review of rFVIIa use in major surgeries.
    Aouba A; Dezamis E; Sermet A; Rothschild C; Hermine O; Lasne D; Torchet MF
    Haemophilia; 2010 Jan; 16(1):54-60. PubMed ID: 19709314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The use of recombinant activated factor VIIa for major bleedings in open heart surgery].
    Ingimarsson JP; Onundarson PT; Valsson F; Vidarsson B; Gudbjartsson T
    Laeknabladid; 2008 Sep; 94(9):607-12. PubMed ID: 18784387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy.
    Ekert H; Brizard C; Eyers R; Cochrane A; Henning R
    Blood Coagul Fibrinolysis; 2006 Jul; 17(5):389-95. PubMed ID: 16788315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coagulation Profile of Patients with Adolescent Idiopathic Scoliosis Undergoing Posterior Spinal Fusion.
    Bosch P; Kenkre TS; Londino JA; Cassara A; Yang C; Waters JH
    J Bone Joint Surg Am; 2016 Oct; 98(20):e88. PubMed ID: 27869629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.
    Boadas A; Fernández-Palazzi F; De Bosch NB; Cedeño M; Ruiz-Sáez A
    Haemophilia; 2011 May; 17(3):422-7. PubMed ID: 21118333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
    Končar IB; Davidović LB; Savić N; Sinđelić RB; Ilić N; Dragas M; Markovic M; Kostic D
    J Vasc Surg; 2011 Apr; 53(4):1032-7. PubMed ID: 21215579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label use of recombinant factor VIIa for treatment of haemorrhage: results from randomized clinical trials.
    Johansson PI
    Vox Sang; 2008 Jul; 95(1):1-7. PubMed ID: 18435677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.